Navigation Links
DFine Secures $30 Million in Series D Funding
Date:10/28/2008

Investment Will Help Drive Advancement of Vertebral Compression Fracture

Treatment Using Ultra-High Viscosity Energy Responsive Bone Cement

SAN JOSE, Calif., Oct. 28 /PRNewswire/ -- DFine, Inc., a developer of minimally invasive solutions for treating vertebral compression fractures (VCFs), has secured a $30 million round of investment in its Series D funding led by BBT Fund LP and Highland Capital Management. Other investors include Prospect Venture Partners and Vanguard Ventures.

DFine is dedicated to developing treatments for VCFs that relieve pain and improve quality of life for patients. More than 700,000 new VCFs occur every year in the United States due to osteoporosis, tumor growth and traumatic injury, accounting for nearly 150,000 hospital admissions and resulting in close to $1.6 billion in annual costs.(1)

The growing U.S. elderly population, particularly Baby Boomers, is increasing the need for new treatments of VCFs to meet their demand for an active lifestyle. In addition, in the United States alone, there are an additional 440,000 osteoporotic-related fractures that go undiagnosed each year.

"Minimally-invasive vertebral compression fracture procedures are a rapidly growing area of the spine market as physicians and patients look for treatments that are safe, effective and improve their quality of life," said Ryan Perras of BBT Fund LP. "Our investment recognizes DFine's unique technology and commitment to innovation and patient care that will drive it to succeed in this market."

Minimally invasive treatment of VCFs, percutaneous vertebral augmentation (also known as vertebroplasty or kyphoplasty), require placement of bone cement into the fractured vertebra. Percutaneous vertebral augmentation offers many benefits compared to a conventional surgical approach including reduced procedure time, shorter hospital stays, shorter recovery period and the elimination of brace usage.

"We saw an opportunity to help streamline the vertebral augmentation procedure while enabling physicians to control the delivery of cement for optimized patient outcomes," said Csaba Truckai, president and chief executive officer of DFine. "We are delighted with the continuing support of our investors. With this investment, we will be able to commercialize the StabiliT Vertebral Augmentation System which we believe will redefine the way vertebral compression fractures are treated, offering benefits to patients and physicians alike."

DFine is led by a dynamic management team and board of directors whose collective experience spans across all aspects of the medical device industry and interventional neuroradiology, neurosurgery and orthopedic surgery.

About DFine

DFine, Inc., a privately held medical device company based in San Jose, Calif., is dedicated to advancing minimally invasive solutions for treating vertebral compression fractures and other spinal disorders to improve quality of life. DFine's innovative system provides physicians with a precise means of delivering ultra-high viscosity bone cement to fractures of the spine in an effort to relieve pain and improve patient outcomes. The company's products include the StabiliT(TM) Vertebral Augmentation System and StabiliT(TM) ER Bone Cement, a proprietary energy responsive polymethylmethacrylate (PMMA) formulation. For more information, visit http://www.dfineinc.com.

(1) Cooper, Grant. Nonoperative treatment of Osteoporatic Compression

Fractures. eMedicine,

http://www.emedicine.com/pmr/TOPIC238.HTM#section~Introduction

Media Contact:

Vanessa Hughes

Porter Novelli Life Sciences

310-444-7019

vanessa.hughes@porternovelli.com


'/>"/>
SOURCE DFine, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ocean Nutrition Canada Limited Secures Their Position as the Largest Omega-3 EPA/DHA Ingredient Supplier in the World
2. Cohera Medical Secures $16.1 Million in Series B Financing
3. Miller, Murtha & Psoras Secures Multimillion-Dollar Settlement for Victim of Industrial Accident at Bethlehem Steel
4. Almost Family Secures $75 Million Revolving Credit Facility
5. 1,000th Uninsured Virginia Patient Secures Access to Quality Medical Care Through Virginia Cares Uninsured Program (VCUP)
6. Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production
7. Global Med Technologies(R), Inc. Secures $6 Million Credit Facility From Silicon Valley Bank for Inlog Acquisition
8. PSS Systems Secures $18 Million in Financing
9. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Italy
10. VeraLight Secures $20 Million Series C Financing
11. OmniGuide(R) Secures $25 Million in Funding to Support Continued Growth and New Market Penetration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... “Spiritual Vitamins: A ... connection with God. “Spiritual Vitamins: A Spiritual Energy Booster” is the creation of ... Publishing, Mathai Yohannan’s new book engages the mind and spirit in a quest ...
(Date:1/24/2017)... ... 2017 , ... Attention women who want bigger breasts but ... fat grafting—taking one’s own fat and putting it in other body part—is a ... Surgeon and Medical Director of MilfordMD Cosmetic Dermatology Surgery & Laser Center, in ...
(Date:1/24/2017)... ... January 23, 2017 , ... United ... the imposition of the Mexico City Policy, also known as the Global Gag ... through Executive action, prohibits foreign non-governmental organizations from receiving any U.S. foreign assistance ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... support them, Dr. Carol Francis, Psychologist in the South Bay area , ... respectful governing for all people and by all people shines as a bright ...
(Date:1/23/2017)... ... , ... PKF O’Connor Davies , LLP, the nation’s 26th largest accounting ... Firm, will participate in the 40th Annual "Empire State Building Run Up" on Feb. ... steps, a vertical distance equal to about a fifth of a mile, to reach ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... YORK , January 24, 2017 ... Ltd (NASDAQ: GENE ), Alder Biopharmaceuticals Inc. (NASDAQ: ... BDSI ), and Egalet Corp. (NASDAQ: EGLT ... was moderately lower on Monday, January 23 rd , 2017, ... shares of health care companies in the S&P 500 also ...
(Date:1/24/2017)... 2017 INTRODUCTION Injectable drug delivery systems ... with vials to prefilled syringes, auto-injectors, pen injectors ... become preferred devices for parenteral administration of drugs. ... rising strongly over the past several years. A ... this format for delivering drugs. The popularity of ...
(Date:1/24/2017)... LONDON , Jan. 23, 2017 The ... revenue in 2015, and it is expected to grow ... peripheral I.V. catheter segment accounted for larger share in ... whereas, among the various end users, the hospital segment ... during the same year. The global peripheral I.V. catheter ...
Breaking Medicine Technology: